Dr. Ferid Murad
Dr. Murad was a co-recipient of the 1998 Nobel Prize in Physiology or Medicine for the discovery that nitric oxide acts as a signalling molecule in the cardiovascular system. Dr. Murad along with Robert F. Furchgott, PhD, and Louis J. Ignarro PhD, identified an entirely new mechanism that explains how blood vessels in the body relax and widen.
Dr. Murad was Chief of Medicine at the Palo Alto VA Medical Center (1981–1986), Associate Chairman, Dept. of Medicine, Stanford University (1984–1986), and Acting Chairman, Dept. of Medicine and Acting Division Chief, Division of Respiratory Medicine from 1986-1988.
Dr. Mike Abrams
PhD, Pharmaceutical Development
Over 35 years of experience in drug discovery and development. Dr. Abrams was the founding CEO of AnorMed and led the company for ten years. He is a co-recipient of the 2009 Georg Charles de Hevesy Nuclear Pioneer Award from the Society of Nuclear Medicine for his work in the discovery of the heart imaging agent Cardiolite.
Managing Director of Product Strategy & Design at M.Y. Capital Management Corp. and a Co-founder and Partner at FDP & Co., Western Canada’s premiere multi-family office.
Ms. Chen is a Business in Vancouver Top Forty under 40 and served on the Board of Directors of the Greater Vancouver Board of Trade, World Trade Center Vancouver and as a member of the Greater Vancouver Board of Trade Policy Council (2016-2018). She also served on the board of the Association of Women in Finance and is a graduate of Citibank’s Global Family Office Leadership Program (2017).
Mr. Daon is an award-winning serial innovator and entrepreneur with 20 years experience in the invention and commercialization of med-tech products. He holds more than 70 patents in prosecution worldwide. He led and advised teams and companies and headed the commercial launch of more than 10 products. Mr. Daon has multi-million dollar licensing and sales cycles experience.